Video Education

CME | Screening and Accurate Diagnosis of Patients With Bipolar Disorder Type I and Type II

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

Drs Goldberg, Swartz, and DelBello discuss the spectrum of bipolar disorder, from major depressive disorder to bipolar I, and assessment strategies for establishing accurate diagnoses, including age, gender, signs and symptoms, and comorbidities to facilitate appropriate treatments and improve patient outcomes.

Available credit: Activity expires: 9/30/2023
0.5 AMA PRA Category 1 Credit™   Cost: FREE
0.5 Participation 

CME | Treatment Options for Bipolar I and Bipolar II Disorder

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

As novel agents join the treatment landscape for bipolar I and bipolar II disorder and new data emerge on existing therapeutics, clinicians need education on the latest evidence of the safety and efficacy profiles of existing and emerging treatments for bipolar I and bipolar II disorder. Join Drs Goldberg, DelBello, and Swartz in examining how to integrate this information into clinical practice and provide efficacious and tolerable treatment for patients with bipolar I and bipolar II disorder.

Available credit: Activity expires: 9/30/2023
0.5 AMA PRA Category 1 Credit™   Cost: FREE
0.5 Participation 

CME | Acute and Maintenance Treatment Strategies for Bipolar Depression: the Focus on Bipolar Depression Type I and Type II

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

Treating bipolar I and bipolar II depression is not one-size-fits-all. Learn from field experts about practice guidelines, novel agents, and approaches to developing personalized treatment plans for patients with bipolar depression type I and type II.

Available credit: Activity expires: 9/30/2023
0.5 AMA PRA Category 1 Credit™   Cost: FREE
0.5 Participation 

CME | Communicating With Patients and Families: Sharing the Treatment Journey of Bipolar Disorder

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

Patients who present with major depressive disorder (MDD) and subthreshold hypomania are often misdiagnosed. Using older criteria, clinicians have diagnosed such patients as having MDD alone or bipolar disorder. Newer diagnostic criteria allow for a diagnosis of MDD with a mixed features specifier. Patients with MDD and subthreshold hypomania are at increased risk of developing bipolar disorder and must be followed carefully. Treating patients with mixed features is challenging, but treatment guidelines have emerged.

Available credit: Activity expires: 9/30/2023
0.5 AMA PRA Category 1 Credit™   Cost: FREE
0.5 Participation 

CME | Acute and Maintenance Treatment Strategies for Bipolar I: Focus on Mixed and Manic Episodes

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

Adopting consensus guidelines while applying new evidence on the latest treatment options can often be a matter of balancing risks, benefits, and tolerability when addressing acute episodes in bipolar I disorder. Sit in on the discussion between three experts as they discuss guideline-directed treatment strategies that address manic and mixed episodes in patients with bipolar I disorder, and listen to one patient’s journey to hope and recovery.

Available credit: Activity expires: 9/30/2023
0.5 AMA PRA Category 1 Credit™    Cost: FREE
0.5 Participation 

CME | Therapeutic Tolerability and Adherence in Bipolar Disorder

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

Involving patients in designing their own treatment strategies according to their tolerability criteria can help combat the 90% nonadherence rate in patients being treated for bipolar disorder. Find out from experts about best practices in addressing patient concerns and balancing tolerability with efficacy and adherence in treating patients with bipolar disorder.

Available credit: Activity expires: 9/30/2023
0.5 AMA PRA Category 1 Credit™    Cost: FREE
0.5 Participation 

Brief Reports

CME | Diagnosis and Pharmacotherapy of Bipolar Depression in Adults

Joseph F. Goldberg, MD 

Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.

Available credit: Activity expires: 6/30/2023
0.5 AMA PRA Category 1 Credit™    Cost: FREE
0.5 Participation 

CME | Diagnosis and Pharmacotherapy of Bipolar Depression in Pediatric Patients

Robert L. Findling, MD, MBA 

What are the evidence-based pharmacologic treatment approaches for pediatric patients with bipolar depression?

Available credit: Activity expires: 6/30/2023
0.5 AMA PRA Category 1 Credit™    Cost: FREE
0.5 Participation 

Academic Highlights

CME | Expanded Treatment Options and Addressing Unmet Needs in the Diagnosis and Treatment of Bipolar Disorder

Joseph F. Goldberg, M.D.; Holly A. Swartz, M.D.; and Melissa P. DelBello, MD, MS

Bipolar disorder presents on a spectrum, with bipolar depression on one end and bipolar I on the other and a host of other presentations in between. As guidelines are updated and new treatments become available, developing individualized treatment regimens is key and collaboration between clinician and patient and family is critical in optimizing patient outcomes. New treatment options can reduce some of the side effect burdens associated with treating bipolar disorder, and clinicians should use measurement-based care to assess whether treatment changes are necessary, which requires engaging with the patient to monitor efficacy and manage side effects.

Available credit:Activity expires: 12/31/2023
1.00 AMA PRA Category 1 Credit™Cost: FREE
1.00 Participation 

CME | Individualizing Treatment Selection for Pediatric and Adult Patients With Bipolar Depression

Robert L. Findling, MD, MBA and Joseph F. Goldberg, MD

Drs Findling and Goldberg offer expertise on the diagnosis and treatment of bipolar disorder in patients of all ages.

Available credit: Activity expires: 12/20/2023
1.00 AMA PRA Category 1 Credit™    Cost: FREE
1.00 Participation 

Identifying Profiles of Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic

Mauricio Tohen, MD, DrPH, MBA; Joseph F. Goldberg, MD; Youssef Hassoun, MD; and Suresh Sureddi, MD

In this article focusing on maintenance treatment of bipolar I disorder, experts discuss functional impairment, the potential for LAI antipsychotics to address nonadherence, and the characteristics of patients who may be helped by LAI antipsychotic treatment.

JCP Journal Articles and Insights Video

CME | Suicide Risk in a National VA Sample: Roles of Psychiatric Diagnosis, Behavior Regulation, Substance Use, and Smoking

Alan C. Swann, MD; David P. Graham, MD; Anna V. Wilkinson, PhD; and Thomas R. Kosten, MD

Predicting suicide is difficult, as suicidal behavior is not linked solely to any single behavior or psychiatric diagnosis. This study compared risk of suicidal behavior among a transdiagnostic sample of Veterans with varying disorders and behaviors.

Available credit: Activity expires: 7/1/2023
1.00 AMA PRA Category 1 Credit™    Cost: FREE
1.00 Participation 

CME | A Systematic Review of Complex Polypharmacy in Bipolar Disorder: Prevalence, Clinical Features, Adherence, and Preliminary Recommendations for Practitioners

Anna M. Kim, MD; Lisa Salstein, MD; and Joseph F. Goldberg, MD 

Do you tend to use combination pharmacotherapy regimens in patients with bipolar disorder? Will patients receiving 3 or more drugs have better outcomes?

Available credit: Activity expires: 6/30/2023
1.0 AMA PRA Category 1 Credit™    Cost: FREE
1.0 Participation 

CME | Predictors of Bipolar Disorder Versus Schizophrenia Diagnosis in a Multicenter First Psychotic Episode Cohort

Estela Salagre, MD; Iria Grande, MD, PhD;
Eduard Vieta, MD, PhD; et al

What features may predict bipolar disorder vs schizophrenia in a person with first-episode psychosis? In this journal CME activity, find out which tools could most aid diagnosis.

Available credit: Activity expires: 12/31/2022
1.0 AMA PRA Category 1 Credit™    Cost: FREE
1.0 Participation 

JCP Insights Video: Complex Polypharmacy in Bipolar Disorder

Joseph F. Goldberg, MD

Patients who present with major depressive disorder (MDD) and subthreshold hypomania are often misdiagnosed. Using older criteria, clinicians have diagnosed such patients as having MDD alone or bipolar disorder. Newer diagnostic criteria allow for a diagnosis of MDD with a mixed features specifier. Patients with MDD and subthreshold hypomania are at increased risk of developing bipolar disorder and must be followed carefully. Treating patients with mixed features is challenging, but treatment guidelines have emerged.